Percorrer por autor "Oliveira, Rosana Rosseto de"
A mostrar 1 - 2 de 2
Resultados por página
Opções de ordenação
- Prevalence and Predictors of Long Covid in a Cohort of Brazilian Adults 12 Months After Acute Infection: A Cross‐Sectional StudyPublication . Covre, Eduardo Rocha; Laranjeira, Carlos; Carreira, Lígia; Höring, Carla Franciele; Góes, Herbert Leopoldo de Freitas; Baldissera, Vanessa Denardi Antoniassi; Marques, Priscila Garcia; Meireles, Viviane Camboin; Tostes, Maria Fernanda do Prado; Oliveira, Rosana Rosseto de; Paiano, Marcelle; Ageno, Rosella Santoro; Moroskoski, Márcia; Alcaraz, Jesús Puente; Vissoci, João Nickenig; Facchini, Luiz Augusto; Salci, Maria; Chew-Graham, CarolynIntroduction: Since the onset of the pandemic in early 2020, various reports have emerged regarding persistent symptoms associated with Covid‐19. Nevertheless, there is insufficient data on the persistence of symptoms over time. This study sought to estimate the prevalence of persistent symptoms 12 months after Covid‐19 infection and identify predictors of long Covid in adults living in the State of Paraná, southern Brazil, according to the level of severity of Covid‐19 infection. Method: An observational and cross‐sectional survey was conducted with Brazilian adults diagnosed with Covid‐19, as assessed from data available in two official Covid‐19 notification databases in Brazil, using telephone interviews. Descriptive statistics, tests of associations and simple and multiple binary logistic regression analysis were used to identify predictors of long Covid. Results: In total, 1033 adults participated in the study. The overall prevalence of long Covid was 60.3% (n = 623). Prevalence was higher in women (67.7%), people aged between 50 and 59 years (65.8%) and in individuals who received treatment in an Intensive Care Unit (ICU) during the acute phase of Covid‐19 infection (74.4%, n = 241). The risk factors associated with a greater chance of developing long Covid were: female (OR 2.38; 95% CI 1.55; 3.66), living in the Brazilian northwest health macro‐region (OR 2.20; 95% CI 1.21; 4.00), presenting multimorbidity (OR 1.86; 95% CI 1.06; 3.28), having an average of six symptoms in the acute phase of Covid‐19 (OR 1.22; 95% CI 1.17; 1.28) and having received treatment in an ICU (OR 4.86; 95% CI 2.83; 8.35) and inpatient ward (OR 2.45; 95% CI 1.47; 4.09). Conclusions: The results highlight the high prevalence of long Covid and support the formulation of health policies capable of minimising the consequences on the population, on the services offered by professionals and on health systems. Patient or Public Contribution: The study topic's importance was based on the patients' experiences in the author's previous research and the need to develop patient‐centred care.
- Self-Reported Post-COVID Symptoms at 18 Months After Infection Among Adults in Southern Brazil: A Cross-Sectional StudyPublication . Brito, Franciele Aline Machado de; Laranjeira, Carlos; Moroskoski, Marcia; Oliveira, Rosana Rosseto de; Salci, Maria Aparecida; Rossoni, Stéfane Lele; Baccon, Wanessa Cristina; Marques, Priscila Garcia; Góes, Herbert Leopoldo de Freitas; Mello, Fernanda Fontes; Blaszczak, Flávia Renata Baldissera da Cruz; Vissoci, João Ricardo Nickenig; Alcaraz, Jesús Puente; Facchini, Luiz Augusto; Carreira, LígiaBackground/Objectives: Currently, there is a limited understanding of the long-term consequences following acute COVID-19, referred to as long COVID. This cross-sectional study aims to analyze the prevalence of persistent signs and symptoms of long COVID, 18 months after primary SARS-CoV-2 infection in adults in southern Brazil. Methods: Using two national databases (the digital registry of SARS-CoV-2 positive cases), 370 individuals living in the state of Paraná (Brazil) were recruited. Data were collected through telephone interviews conducted in 2021 and 2022. Results: The overall prevalence of long COVID was 66.2% among study participants. During the acute phase of infection, the most common symptom clusters included neurological symptoms (87.0%; n = 318), followed by respiratory (82.0%; n = 301), musculoskeletal (66.0%; n = 241), digestive (50.0%; n = 184), psychological (38.0%; n = 138), and endocrine symptoms (28.0%; n = 104). In the 18 month follow-up, the main persistent symptoms were memory loss (42.7%), fatigue (32.2%), anxiety (23.5%), dyspnea (19.7%), and hair loss (19.7%). The proportion of participants with long COVID was statistically higher in females (73.9%), those with a family income below two minimum wages (94.7%), those who do not practice physical activity (83.3%), those who report poor sleep quality (93.3%), those who use long-term medication (85.9%), those who needed health care in the previous six months (87.3%), those who required professional and/or family care (79.3%), those who were in the ICU (79.0%), and those who used ventilatory support (77.5%). Conclusions: Long COVID is a complex condition that requires long-term monitoring and investment in health services due to its high prevalence and the health consequences in the population.